Viewing Study NCT04023227

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 5:06 AM
Ignite Modification Date: 2025-12-26 @ 4:10 AM
Study NCT ID: NCT04023227
Status: COMPLETED
Last Update Posted: 2025-11-19
First Post: 2019-07-10
Is NOT Gene Therapy: False
Has Adverse Events: False
Brief Title: Efficacy and Safety of Sacubitril/Valsartan Compared With Enalapril on Morbidity, Mortality, and NT-proBNP Change in Patients With CCC
Sponsor: Novartis Pharmaceuticals
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Chagas Disease View
None Heart Failure View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Chagas' disease View
None heart failure View
None angiotensin receptor-neprilysin inhibitor View
None ARNI View
None ARB View
None ACEI View
None sacubitril/valsartan View
None enalapril View